306 related articles for article (PubMed ID: 33813611)
21. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience.
Fogaça MV; Reis FM; Campos AC; Guimarães FS
Eur Neuropsychopharmacol; 2014 Mar; 24(3):410-9. PubMed ID: 24321837
[TBL] [Abstract][Full Text] [Related]
22. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
[TBL] [Abstract][Full Text] [Related]
23. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
[TBL] [Abstract][Full Text] [Related]
24. The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors.
Gomes FV; Resstel LB; Guimarães FS
Psychopharmacology (Berl); 2011 Feb; 213(2-3):465-73. PubMed ID: 20945065
[TBL] [Abstract][Full Text] [Related]
25. Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress.
Granjeiro EM; Gomes FV; Guimarães FS; Corrêa FM; Resstel LB
Pharmacol Biochem Behav; 2011 Oct; 99(4):743-8. PubMed ID: 21771609
[TBL] [Abstract][Full Text] [Related]
26. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.
Boggs DL; Surti T; Gupta A; Gupta S; Niciu M; Pittman B; Schnakenberg Martin AM; Thurnauer H; Davies A; D'Souza DC; Ranganathan M
Psychopharmacology (Berl); 2018 Jul; 235(7):1923-1932. PubMed ID: 29619533
[TBL] [Abstract][Full Text] [Related]
27. The effects of cannabidiol and analgesic expectancies on experimental pain reactivity in healthy adults: A balanced placebo design trial.
De Vita MJ; Maisto SA; Gilmour CE; McGuire L; Tarvin E; Moskal D
Exp Clin Psychopharmacol; 2022 Oct; 30(5):536-546. PubMed ID: 34251840
[TBL] [Abstract][Full Text] [Related]
28. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.
Crippa JA; Derenusson GN; Ferrari TB; Wichert-Ana L; Duran FL; Martin-Santos R; Simões MV; Bhattacharyya S; Fusar-Poli P; Atakan Z; Santos Filho A; Freitas-Ferrari MC; McGuire PK; Zuardi AW; Busatto GF; Hallak JE
J Psychopharmacol; 2011 Jan; 25(1):121-30. PubMed ID: 20829306
[TBL] [Abstract][Full Text] [Related]
29. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
30. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
31. Effect of prior foot shock stress and Δ
Rock EM; Limebeer CL; Petrie GN; Williams LA; Mechoulam R; Parker LA
Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834
[TBL] [Abstract][Full Text] [Related]
32. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
[TBL] [Abstract][Full Text] [Related]
33. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
[TBL] [Abstract][Full Text] [Related]
34. Effects of cannabidiol on fear conditioning in anxiety disorders: decreased threat expectation during retention, but no enhanced fear re-extinction.
Kwee CMB; van der Flier FE; Duits P; van Balkom AJLM; Cath DC; Baas JMP
Psychopharmacology (Berl); 2024 Apr; 241(4):833-847. PubMed ID: 38044339
[TBL] [Abstract][Full Text] [Related]
35. Effects of cannabidiol on psychosocial stress, situational anxiety and nausea in a virtual reality environment: a protocol for a single-centre randomised clinical trial.
Bawa Z; McCartney D; Bedoya-Pérez M; Lau NS; Fox R; MacDougall H; McGregor IS
BMJ Open; 2024 Mar; 14(3):e082927. PubMed ID: 38531572
[TBL] [Abstract][Full Text] [Related]
36. Effects of cannabidiol in cannabis flower: Implications for harm reduction.
Gibson LP; Karoly HC; Ellingson JM; Klawitter J; Sempio C; Squeri JE; Bryan AD; Bidwell LC; Hutchison KE
Addict Biol; 2022 Jan; 27(1):e13092. PubMed ID: 34467598
[TBL] [Abstract][Full Text] [Related]
37. Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series.
Elms L; Shannon S; Hughes S; Lewis N
J Altern Complement Med; 2019 Apr; 25(4):392-397. PubMed ID: 30543451
[TBL] [Abstract][Full Text] [Related]
38. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.
Hutten NRPW; Arkell TR; Vinckenbosch F; Schepers J; Kevin RC; Theunissen EL; Kuypers KPC; McGregor IS; Ramaekers JG
Psychopharmacology (Berl); 2022 Nov; 239(11):3731-3741. PubMed ID: 36227352
[TBL] [Abstract][Full Text] [Related]
39. A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single-dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers.
Hosseini A; McLachlan AJ; Lickliter JD
Br J Clin Pharmacol; 2021 Apr; 87(4):2070-2077. PubMed ID: 33075170
[TBL] [Abstract][Full Text] [Related]
40. Investigating the Relationship Between Cannabis Expectancies and Anxiety, Depression, and Pain Responses After Acute Flower and Edible Cannabis Use.
Chen MY; Kramer EB; Gibson LP; Bidwell LC; Hutchison KE; Bryan AD
Cannabis Cannabinoid Res; 2024 Apr; ():. PubMed ID: 38608236
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
